BioLife Solutions (BLFS) 10-Q 9 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 06, 2020
Document Information [Line Items]
Entity Central Index Key	0000834365
Entity Registrant Name	BIOLIFE SOLUTIONS INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-36362
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3076866
Entity Address, Address Line One	3303 Monte Villa Parkway, Suite 310
Entity Address, City or Town	Bothell
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98021
City Area Code	425
Local Phone Number	402-1400
Title of 12(b) Security	BioLife Solutions, Inc. Common Shares
Trading Symbol	BLFS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		32,735,912

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 93,984	$ 6,448
Restricted cash in escrow	15,000
Accounts receivable, trade, net	6,095	5,345
Inventories	11,037	10,972
Prepaid expenses and other current assets	1,668	1,348
Total current assets	127,784	24,113
Assets held for rent, net	5,131	3,922
Property and equipment, net	5,300	5,572
Operating lease right-of-use assets, net	585	1,040
Long-term deposits and other assets	35	50
Investments	3,610	2,500
Accrued interest receivable	54
Intangible assets, net	19,882	21,982
Goodwill	33,506	33,637
Total assets	195,887	92,816
Current liabilities
Accounts payable	2,355	3,119
Accrued expenses and other current liabilities	3,364	3,369
Lease liabilities, operating, current portion	729	804
Contingent consideration, current portion		377
Warrant liability, current portion	1,914
Total current liabilities	8,362	7,669
Warrant liability, long-term		39,602
Contingent consideration, long-term	386	1,537
Lease liabilities, operating, long-term	26	550
Other long-term liabilities	262	4
Total liabilities	9,036	49,362
Commitments and Contingencies (Note 11)
Shareholders’ equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	0	0
Common stock, $0.001 par value; 150,000,000 shares authorized, 32,131,165 and 20,825,452 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	32	21
Additional paid-in capital	282,076	143,485
Accumulated deficit	(95,257)	(100,052)
Total shareholders’ equity	186,851	43,454
Total liabilities and shareholders’ equity	$ 195,887	$ 92,816

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	32,131,165	20,825,452
Common stock, outstanding (in shares)	32,131,165	20,825,452
Series A Preferred Stock [Member]
Preferred stock, shares designated (in shares)	4,250	4,250
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue	$ 11,279,000	$ 6,604,000	$ 33,361,000	$ 19,075,000
Operating expenses
Cost of product and rental revenue (exclusive of intangible assets amortization)	4,826,000	2,094,000	13,893,000	5,710,000
Research and development	1,725,000	1,032,000	4,865,000	2,082,000
Sales and marketing	1,588,000	1,250,000	4,530,000	3,032,000
General and administrative	3,503,000	2,348,000	9,916,000	6,707,000
Intangible assets amortization	706,000	361,000	2,100,000	465,000
Acquisition costs	179,000	291,000	417,000	538,000
Change in fair value of contingent consideration	(2,000)		(1,528,000)	0
Total operating expenses	12,525,000	7,376,000	34,193,000	18,534,000
Operating income (loss)	(1,246,000)	(772,000)	(832,000)	541,000
Other income (expense)
Change in fair value of warrant liability	(1,005,000)	1,128,000	4,467,000	(14,949,000)
Change in fair value of investments	1,110,000	0	1,110,000	0
Interest income	16,000	110,000	63,000	417,000
Interest expense	(3,000)	(1,000)	(4,000)	(5,000)
Other expense	(5,000)	(13,000)	(9,000)	(13,000)
Loss from equity method investment in SAVSU		(291,000)	0	(739,000)
Gain on Acquisition of SAVSU	0	10,108,000	0	10,108,000
Total other income (expenses)	113,000	11,041,000	5,627,000	(5,181,000)
Net income (loss) before provision for income taxes	(1,133,000)	10,269,000	4,795,000	(4,640,000)
Income tax (benefit)	0	0	0	0
Net income (loss)	(1,133,000)	10,269,000	4,795,000	(4,640,000)
Net income attributable to common stockholders:
Basic	(1,133,000)	8,380,000	4,322,000	(4,640,000)
Diluted	$ (1,133,000)	$ 8,862,000	$ 279,000	$ (4,640,000)
Earnings per share attributable to common stockholders
Basic (in dollars per share)	$ (0.04)	$ 0.42	$ 0.17	$ (0.24)
Diluted (in dollars per share)	$ (0.04)	$ 0.35	$ 0.01	$ (0.24)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic (in shares)	31,639,420	19,735,364	25,418,375	19,071,722
Diluted (in shares)	31,639,420	25,343,112	29,412,538	19,071,722
Product [Member]
Revenue	$ 10,804,000	$ 6,422,000	$ 32,020,000	$ 18,864,000
Rental Revenue [Member]
Revenue	$ 475,000	$ 182,000	$ 1,341,000	$ 211,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member]Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018	0	18,547,406
Balance at Dec. 31, 2018	$ 0	$ 19	$ 113,008	$ (98,395)	$ 14,632
Stock-based compensation	$ 0	$ 0	2,179	0	2,179
Stock option exercises (in shares)	0	474,237
Stock option exercises	$ 0	$ 0	841	0	841
Warrant exercises (in shares)		116,500
Warrant exercises		$ 0	2,247	0	2,247
Stock issued – on vested RSUs (in shares)	0	106,682
Stock issued – on vested RSUs	$ 0	$ 0	0	0	0
Net income	$ 0	$ 0	0	(4,640)	(4,640)
Shares issued as consideration in SAVSU acquisition (in shares)		1,100,000
Shares issued as consideration in SAVSU acquisition		$ 1	19,931	0	19,932
Balance (in shares) at Sep. 30, 2019	0	20,344,825
Balance at Sep. 30, 2019	$ 0	$ 20	138,206	(103,035)	35,191
Balance (in shares) at Jun. 30, 2019	0	18,898,609
Balance at Jun. 30, 2019	$ 0	$ 19	115,357	(113,304)	2,072
Stock-based compensation	$ 0	$ 0	829	0	829
Stock option exercises (in shares)	0	238,176
Stock option exercises	$ 0	$ 0	378	0	378
Warrant exercises (in shares)		87,500
Warrant exercises		$ 0	1,711	0	1,711
Stock issued – on vested RSUs (in shares)	0	20,540
Stock issued – on vested RSUs	$ 0	$ 0	0	0	0
Net income	$ 0	$ 0	0	10,269	10,269
Shares issued as consideration in SAVSU acquisition (in shares)	0	1,100,000
Shares issued as consideration in SAVSU acquisition	$ 0	$ 1	19,931	0	19,932
Balance (in shares) at Sep. 30, 2019	0	20,344,825
Balance at Sep. 30, 2019	$ 0	$ 20	138,206	(103,035)	35,191
Balance (in shares) at Dec. 31, 2019	0	20,825,452
Balance at Dec. 31, 2019	$ 0	$ 21	143,485	(100,052)	43,454
Stock issued as 2019 bonus payout	$ 0	$ 0	314	0	314
Sale of common stock, net of costs (in shares)	0	7,856,012
Sale of common stock, net of costs	$ 0	$ 8	100,113	0	100,121
Common stock issued for services (in shares)		3,175
Common stock issued for services		$ 0	60	0	60
Stock-based compensation	$ 0	$ 0	3,818	0	3,818
Stock option exercises (in shares)	0	528,793
Stock option exercises	$ 0	$ 0	1,028	0	1,028
Cashless exercises of 3,871,405 warrants (in shares)	0	2,747,970
Cashless exercises of warrants	$ 0	$ 3	33,108	0	33,111
Warrant exercises (in shares)		8,500
Warrant exercises		$ 0	150	0	150
Stock issued – on vested RSUs (in shares)	0	161,263
Stock issued – on vested RSUs	$ 0	$ 0	0	0	0
Net income	$ 0	$ 0	0	4,795	4,795
Balance (in shares) at Sep. 30, 2020	0	32,131,165
Balance at Sep. 30, 2020	$ 0	$ 32	282,076	(95,257)	186,851
Balance (in shares) at Jun. 30, 2020	0	25,982,367
Balance at Jun. 30, 2020	$ 0	$ 26	199,941	(94,124)	105,843
Sale of common stock, net of costs (in shares)	0	5,951,250
Sale of common stock, net of costs	$ 0	$ 6	80,201	0	80,207
Common stock issued for services (in shares)	0	3,175
Common stock issued for services	$ 0	$ 0	60	0	60
Stock-based compensation	$ 0	$ 0	1,560	0	1,560
Stock option exercises (in shares)	0	118,000
Stock option exercises	$ 0	$ 0	244	0	244
Warrant exercises (in shares)		3,500
Warrant exercises		$ 0	70	0	70
Stock issued – on vested RSUs (in shares)	0	72,873
Stock issued – on vested RSUs	$ 0	$ 0	0	0	0
Net income	$ 0	$ 0	0	(1,133)	(1,133)
Balance (in shares) at Sep. 30, 2020	0	32,131,165
Balance at Sep. 30, 2020	$ 0	$ 32	$ 282,076	$ (95,257)	$ 186,851

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) (Parentheticals) - shares	May 14, 2020	Sep. 30, 2020
WAVI Holding AG and Taurus4757 GmbH Warrants [Member]
Cashless warrant exercises (in shares)	3,871,405	3,871,405
Cashless warrant exercises (in shares)		3,879,905

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income (loss)	$ 4,795,000	$ (4,640,000)
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	1,454,000	373,000
Amortization of intangible assets	2,100,000	465,000
Non cash lease expense	455,000	361,000
Stock-based compensation	3,818,000	2,179,000
Loss from equity method investment in SAVSU	0	739,000
Gain on acquisition of SAVSU	0	(10,108,000)
Change in fair value of investments	(1,110,000)	0
Change in fair value of contingent consideration	(1,528,000)	0
Change in fair value of warrant liability	(4,467,000)	14,949,000
Stock issued for services	30,000	0
Other	9,000	15,000
Change in operating assets and liabilities
Accounts receivable, trade, net	(820,000)	(372,000)
Inventories	(65,000)	(1,730,000)
Prepaid expenses and other current assets	68,000	(272,000)
Accounts payable	(604,000)	377,000
Other payables	(406,000)	(87,000)
Accrued compensation and other current liabilities	689,000	65,000
Other	(30,000)	(98,000)
Net cash provided by operating activities	4,388,000	2,216,000
Cash flows from investing activities
Investment in iVexSol	0	(1,000,000)
Purchase of property and equipment	(370,000)	(356,000)
Purchase of assets held for rent, net	(1,791,000)	(453,000)
Proceeds from sale of equipment	3,000	0
Net cash used in investing activities	(2,658,000)	(12,997,000)
Cash flows from financing activities
Proceeds from PPP Loan	2,175,000	0
Payoff of PPP Loan	(2,175,000)	0
Payments of contingent consideration	(483,000)	0
Proceeds from sale of common stock, net of $6.2 million of costs	100,251,000	0
Proceeds from exercise of common stock options	1,028,000	841,000
Proceeds from exercise of warrants	40,000	553,000
Payments of costs related to stock issuance	0	(44,000)
Other	(30,000)	(21,000)
Net cash provided by financing activities	100,806,000	1,329,000
Net increase (decrease) in cash, cash equivalents and restricted cash	102,536,000	(9,452,000)
Cash, cash equivalents and restricted cash - beginning of period	6,448,000	30,657,000
Cash, cash equivalents and restricted cash - end of period	108,984,000	21,205,000
Non-cash investing and financing activities
Cashless exercise of warrants reclassed from warrant liability to common stock	33,111,000	0
Reclassification of warrant liability to equity upon exercise	110,000	1,694,000
Purchase of property & equipment not yet paid	29,000	146,000
Financing costs paid in a prior period	130,000	0
Deferred financing costs not yet paid	0	53,000
Purchase of equipment with debt	270,000	0
Stock issued as consideration to acquire SAVSU	0	19,932,000
Prepayment of Services [Member]
Non-cash investing and financing activities
Stock issued	30,000	0
Bonus Consideration [Member]
Non-cash investing and financing activities
Stock issued	314,000	0
SciSafe Holdings, Inc [Member]
Cash flows from investing activities
Payments related to the acquisition, net of cash acquired	(500,000)	0
SAVSU [Member]
Cash flows from investing activities
Payments related to the acquisition, net of cash acquired	0	1,251,000
Astero [Member]
Cash flows from investing activities
Payments related to the acquisition, net of cash acquired	$ 0	$ (12,439,000)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) - USD ($) $ in Millions	Jul. 07, 2020	Sep. 30, 2020
Stock issuance costs	$ 6.1	$ 6.2

Note 1 - Organization and Signi

Note 1 - Organization and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	1. Organization and Significant Accounting Policies Business BioLife Solutions, Inc. (“BioLife,” “us,” “we,” “our,” or the “Company”) is a leading developer, manufacturer and supplier of a portfolio of cell and gene therapy bioproduction products and services including proprietary biopreservation media, automated thawing devices, cloud-connected shipping containers, and freezer technology. Our CryoStor® freeze media and HypoThermosol® hypothermic storage are optimized to preserve cells during distribution and storage. These novel biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. Our ThawSTAR® product line is comprised of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. These products improve the quality of high-value, temperature-sensitive biologic therapies by standardizing the thawing process and reducing the risks of contamination and overheating which are inherent with the use of traditional water baths. Our evo® shipping containers are innovative high-performance cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. Basis of Presentation The condensed consolidated financial statements included herein have been prepared by BioLife Solutions, Inc. in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10 10 X not 10 December 31, 2019. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Astero Bio Corporation (“Astero,” and the Astero product line, “ThawSTAR” acquired on April 1, 2019), August 8, 2019), November 12, 2019). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows. The results of operations for the interim periods presented are not Financial Statement Reclassification Certain classifications on the Condensed Consolidated Statements of Cash Flows related to non cash lease expense and accrued expenses and other current liabilities for the three nine September 30, 2019 no Significant Accounting Policies There have been no nine September 30, 2020, 10 Liquidity and Capital Resources On September 30, 2020 December 31, 2019, April 1, 2019 2019 second 2020. August 8, 2019, not November 12, 2019, not October 1, 2020, not On July 7, 2020, As of September 30, 2020, third October 1, 2020, Based on our current expectations with respect to our future revenue and expenses, we believe that our current level of cash and cash equivalents including proceeds from the public offering, will be sufficient to meet our liquidity needs for at least the foreseeable future. However, the Company may 19 may not Risks and Uncertainties COVID- 19 On March 10, 2020, 2, 2019 19” 19 19, not three March 31, 2020, second June 30, 2020, third September 30, 2020, third September 30, 2020 second June 30, 2020. may The Company reviews capital and amortizing intangible assets (long-lived assets) for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount may not 19 June 30, 2020 19. As a result of the Company’s outlook for near term revenue from the ThawSTAR and freezer product lines, estimated undiscounted cash flow projections were developed to determine if any impairment of the related intangible assets was warranted. After conducting such review, the Company determined that there was no impairment of the remaining long-lived assets as of June 30, 2020. 19 The Company revised the revenue projections for the ThawSTAR and freezer product lines in the second June 30, 2020 third September 30, 2020 two not June 30, 2020, September 30, 2020 third September 30, 2020. The Company may 19 third Any disruption and volatility in the global capital markets as a result of the pandemic may 19 not The ultimate extent to which the COVID- 19 19 On March 27, 2020, may As of March 30, 2020, 50% 2021 50% 2022. Concentrations of credit risk and business risk In the three September 30, 2020, nine September 30, 2020, three September 30, 2019, three nine September 30, 2019, No 10% nine September 30, 2020 2019. three September 30, 2020 2019, 2019 2020, December 31, 2020. September 30, 2020, December 31, 2019, The following table represents the Company’s total revenue by geographic area (based on the location of the customer): Three Months Ended September 30, Nine Months Ended September 30, Revenue by customers’ geographic locations 2020 2019 2020 2019 United States 73 % 76 % 73 % 70 % Canada 11 % 12 % 13 % 17 % Europe, Middle East, Africa (EMEA) 13 % 11 % 12 % 11 % Other 3 % 1 % 2 % 2 % Total revenue 100 % 100 % 100 % 100 % Recent accounting pronouncements In June 2016, No. 2016 13, 326 2016 13 2016 13 December 15, 2022, In August 2018, 2018 13, 820 2018 13 8: December 31, 2020 January 1, 2020 no In August 2018, No. 2018 15, 350 40 2018 15 December 15, 2019, January 1, 2020 no In December 2019, 2019 12, 740 2019 12 740, not 2019 12 December 31, 2021, no 2019 12

Note 2 - Fair Value Measurement

Note 2 - Fair Value Measurement	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Fair Value Disclosures [Text Block]	2. Fair Value Measurement In accordance with FASB ASC Topic 820, 820” 820 820 three Level 1 Level 2 1 not Level 3 September 30, 2020 December 31, 2019, 3 For the investment in convertible debt, the significant Level 3 September 2019 may The fair value of the Astero contingent consideration liability was initially valued based on unobservable inputs using a Black-Scholes valuation model. These inputs included the estimated amount and timing of projected future revenue, a discount rate of 17.5%, risk-free rates between 2.30% and 2.43% and revenue volatility of 90%. Significant increases (decreases) in any of those inputs in isolation would result in a significantly higher (lower) fair value measurement. Generally, changes used in the assumptions for projected future revenue and revenue volatility would be accompanied by a directionally similar change in the fair value measurement. Conversely, changes in the discount rate would be accompanied by a directionally opposite change in the related fair value measurement. However, due to the contingent consideration having a maximum payout amount, changes in these assumptions would not September 30, 2020, September 30, 2020 December 31, 2019 may The fair value of the CBS contingent consideration liability was initially valued based on unobservable inputs using a Monte Carlo simulation. These inputs included the estimated amount and timing of projected future revenue, a discount rate of 26.0%, a risk-free rate of approximately 1.74% and revenue volatility of 70%. Significant increases (decreases) in any of those inputs in isolation would result in a significantly higher (lower) fair value measurement. Generally, changes used in the assumptions for projected future revenue and revenue volatility would be accompanied by a directionally similar change in the fair value measurement. Conversely, changes in the discount rate would be accompanied by a directionally opposite change in the related fair value measurement. However, due to the contingent consideration having a maximum payout amount, changes in these assumptions would not September 30, 2020, September 30, 2020 December 31, 2019 may For the warrant liability, the significant Level 3 one not may There were no nine September 30, 2020 not The following tables set forth the Company’s financial assets measured at fair value on a recurring basis as of September 30, 2020 December 31, 2019, three (In thousands) As of September 30, 2020 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 93,984 $ — $ — $ 93,984 Restricted cash held in escrow 15,000 — — 15,000 Convertible debt held at fair value — — 2,110 2,110 Total 108,984 — 2,110 111,094 Liabilities: Contingent consideration - business combinations — — 386 386 Warrant liability — — 1,914 1,914 Total $ — $ — $ 2,300 $ 2,300 As of December 31, 2019 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,448 $ — $ — $ 6,448 Convertible debt held at fair value — — 1,000 1,000 Total 6,448 — 1,000 7,448 Liabilities: Contingent consideration - business combinations — — 1,914 1,914 Warrant liability — — 39,602 39,602 Total $ — $ — $ 41,516 $ 41,516 The fair values of money market funds classified as Level 1 3 no 3 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 1,000 $ — $ 1,000 $ — Purchases — 1,000 — 1,000 Change in fair value recognized in net income 1,110 — 1,110 — Balance, end of period $ 2,110 $ 1,000 $ 2,110 $ 1,000 The following tables present the changes in fair value of contingent consideration liabilities which are measured using Level 3 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 388 $ 1,492 $ 1,914 $ — Additions — — — 1,492 Change in fair value recognized in net income (2 ) — (1,528 ) — Payments earned, reclassified to accrued liabilities — — — — Balance, end of period $ 386 $ 1,492 $ 386 $ 1,492 The following tables present the changes in fair value of warrant liabilities which are measured using Level 3 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 963 $ 44,194 $ 39,602 $ 28,516 Exercised warrants (54 ) (1,295 ) (33,221 ) (1,694 ) Change in fair value recognized in net income 1,005 (1,128 ) (4,467 ) 14,949 Balance, end of period $ 1,914 $ 41,771 $ 1,914 $ 41,771

Note 3 - Acquisitions

Note 3 - Acquisitions	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Business Combination Disclosure [Text Block]	3. Acquisitions Astero Acquisition On April 1, 2019, In connection with the acquisition, the Company paid (i) a base payment in the amount of $12.5 million consisting of an initial cash payment of $8.0 million at the closing of the transactions, subject to adjustment for working capital, net debt and transaction expenses, and a deferred cash payment that was paid into escrow and subsequently paid to Astero of $4.5 million which was payable upon the earlier of Astero meeting certain product development milestones or one 2019, 2020 2021 second 2020 2019 2021, three 2019 2021. Consideration transferred The Astero acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, three not may Total consideration recorded for the acquisition of Astero is as follows (amounts in thousands): Cash consideration $ 12,521 Contingent consideration 1,491 Working capital adjustment (71 ) Total consideration transferred $ 13,941 Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their estimated fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from Astero as of March 31, 2019. Cash and cash equivalents $ 11 Accounts receivable, net 154 Inventory 456 Customer relationships 160 Tradenames 470 Developed technology 2,840 In-process research and development 650 Goodwill 9,515 Other assets 99 Accounts payable (250 ) Other liabilities (164 ) Fair value of net assets acquired $ 13,941 The fair value of Astero’s identifiable intangible assets and estimated useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 160 4 Tradenames 470 9 Developed technology 2,840 5 – 9 In-process research and development 650 9 Total identifiable intangible assets $ 4,120 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three third Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $9.5 million represents future economic benefits expected to arise from synergies from combining operations and commercial organizations to increase market presence and the extension of existing customer relationships. All but $1.1 million of the goodwill recorded is not SAVSU Acquisition On August 8, 2019, not August 8, 2019, Consideration transferred The SAVSU acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, 100% not Under the acquisition method of accounting, the assets acquired and liabilities assumed from SAVSU were recorded as of the acquisition date, at their respective fair values, and consolidated with those of BioLife. The fair value of the net tangible assets acquired is estimated to be approximately $4.2 million, the fair value of the intangible assets acquired is estimated to be approximately $12.2 million, and the residual goodwill is estimated to be approximately $19.5 million. The fair value estimates required critical estimates, including, but not may Total consideration paid for the acquisition of SAVSU is as follows (amounts in thousands): Stock consideration for 55.6% equity interest purchased $ 19,932 This stock consideration plus the fair value of our existing equity investment in SAVSU of $15.9 million results in the total purchase price for accounting purposes of $35.8 million. Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their estimated fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from SAVSU as of August 7, 2019. Cash and cash equivalents $ 1,251 Accounts receivable, net 753 Prepaid expenses and other current assets 19 Property, plant and equipment, net 546 Operating right-of-use asset 233 Assets held for rent, net 2,441 Customer relationships 80 Tradenames 1,320 Developed technology 10,750 Goodwill 21,037 Accounts payable and accrued expenses (807 ) Deferred tax liabilities (1,541 ) Other liabilities (232 ) Fair value of net assets acquired $ 35,850 The fair value of SAVSU’s identifiable intangible assets and estimated useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 80 6 Tradenames 1,320 9 Developed technology 10,750 7 – 8 Total identifiable intangible assets $ 12,150 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $21.0 million represents future economic benefits expected to arise from synergies from combining operations and commercial organizations to increase market presence and the extension of existing customer relationships. None Custom Biogenic Systems Acquisition On November 10, 2019, November 12, 2019. In connection with the CBS Acquisition, we paid to CBS (i) a base payment in the amount of $15.0 million, consisting of a cash payment of $11.0 million paid at the closing of the CBS Acquisition, less a cash holdback escrow of $550,000 to satisfy certain indemnification claims, and an aggregate number of shares of our common stock, with an aggregate fair value equal to $4.0 million, less a holdback escrow of shares of Common Stock with an aggregate value equal to $3.0 million to satisfy potential payments related to any product liability claims outstanding as of March 13, 2019, 2020, 2021, 2022, 2023 2024 not The CBS Acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, not may Total consideration transferred (in thousands): Cash consideration $ 11,000 Stock consideration 4,000 Contingent consideration 856 Total consideration transferred $ 15,856 Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from CBS as of November 11, 2019. Accounts receivable, net $ 1,044 Inventory 3,232 Prepaid expenses and other current assets 29 Property, plant and equipment, net 3,615 Customer relationships 560 Tradenames 800 Developed technology 5,430 Goodwill 2,954 Accounts payable (1,197 ) Other liabilities (611 ) Fair value of net assets acquired $ 15,856 The fair value of CBS’s identifiable intangible assets and weighted average useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 560 6 Tradenames 800 6 Developed technology 5,430 9 Total identifiable intangible assets $ 6,790 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $3.0 million represents future economic benefits expected to arise from synergies from combining operations and commercial organizations to increase market presence and the extension of existing customer relationships. All of the goodwill recorded is expected to be deductible for income tax purposes.

Note 4 - Inventory

Note 4 - Inventory	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. Inventory Inventory consists of the following at September 30, 2020 December 31, 2019: (In thousands) September 30, 2020 December 31, 2019 Raw materials $ 2,731 $ 2,979 Work in progress 2,252 1,896 Finished goods 6,054 6,097 Total $ 11,037 $ 10,972

Note 5 - Assets Held for Rent

Note 5 - Assets Held for Rent	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Assets Held For Rent [Text Block]	5. Assets held for rent Assets held for rent consist of the following at September 30, 2020 December 31, 2019: (In thousands) September 30, 2020 December 31, 2019 Shippers placed in service $ 4,666 $ 3,073 Accumulated deprecation (755 ) (174 ) Net 3,911 2,899 Shippers and related components in production 1,220 1,023 Total $ 5,131 $ 3,922 Shippers and related components in production include shippers complete and ready to be deployed and placed in service upon a customer order, shippers in the process of being assembled, and components available to build shippers. We recognized $186,000 and $581,000 in depreciation expense related to assets held for rent during the three nine September 30, 2020. three nine September 30, 2019.

Note 6 - Goodwill and Intangibl

Note 6 - Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	6. Goodwill and Intangible Assets Goodwill Goodwill represents the difference between the purchase price and the estimated fair value of identifiable assets acquired and liabilities assumed. Goodwill acquired in a business combination and determined to have an indefinite useful life is not 350. nine September 30, 2020: (In thousands) Balance as of December 31, 2019 $ 33,637 Correction of an error related to CBS goodwill (131 ) Balance as of September 30, 2020 $ 33,506 We adjusted goodwill from the CBS Acquisition related to an immaterial error of $131,000 in payables that were paid during closing and incorrectly recorded as liabilities in our purchase price accounting as of December 31, 2019. Intangible Assets Intangible assets, net consisted of the following at September 30, 2020: (In thousands, except weighted average useful life) September 30, 2020 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (161 ) $ 639 4.5 Tradenames 2,590 (372 ) 2,218 6.9 Technology – acquired (1) 19,670 (2,646 ) 17,024 7.3 Total intangible assets $ 23,060 $ (3,179 ) $ 19,881 7.2 ( 1 April 1, 2020, Intangible assets, net consisted of the following at December 31, 2019: (In thousands, except weighted average useful life) December 31, 2019 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (51 ) $ 749 5.6 Tradenames 2,590 (123 ) 2,467 8.1 Technology – acquired 19,020 (904 ) 18,116 8.4 In-process R&D (2) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,078 ) $ 21,982 8.3 ( 2 not April 1, 2020, 1 Amortization expense for finite-lived intangible assets was $706,000 and $2.1 million for the three nine September 30, 2020, three nine September 30, 2019. second 2020, September 30, 2020, (In thousands) For the Years Ended December 31, Estimated Amortization Expense 2020 (3 months remaining) $ 705 2021 2,825 2022 2,825 2023 2,795 2024 2,770 Thereafter 7,961 Total $ 19,881

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	7. Share-based Compensation Service Vesting-Based Stock Options The following is a summary of service vesting-based stock option activity for the nine September 30, 2020 September 30, 2020: Nine Month Period Ended September 30, 2020 Wtd. Avg. Exercise Options Price Outstanding at beginning of year 1,570,455 $ 1.96 Granted — $ — Exercised (511,680 ) $ 1.95 Forfeited — $ — Expired — $ — Outstanding service vesting-based at September 30, 2020 1,058,775 $ 1.96 Service vesting-based options exercisable at September 30, 2020 1,039,399 $ 1.94 We recognized stock compensation expense related to service vesting-based options of $15,000 and $65,000 during the three September 30, 2020 2019, nine September 30, 2020 September 30, 2019, September 30, 2020, September 30, 2020. three September 30, 2020 2019 nine September 30, 2020 2019 nine September 30, 2020 2019. September 30, 2020 September 30, 2020 Performance-based Stock Options The following is a summary of performance-based stock option activity for the nine September 30, 2020, September 30, 2020: Nine Month Period Ended September 30, 2020 Wtd. Avg. Exercise Options Price Outstanding at beginning of year 737,497 $ 1.64 Granted — $ — Exercised (17,113 ) $ 1.64 Outstanding performance-based at September 30, 2020 720,384 $ 1.64 Performance-based options exercisable at September 30, 2020 720,384 $ 1.64 All compensation cost of performance-based stock options outstanding was recognized as of December 31, 2018. September 30, 2020, September 30, 2020. three nine September 30, 2020 none three nine September 30, 2019 September 30, 2020 There were no three nine September 30, 2020 2019. Restricted Stock Service vesting-based restricted stock The following is a summary of service vesting-based restricted stock activity for the nine September 30, 2020, September 30, 2020: Nine Month Period Ended September 30, 2020 Service vesting-based restricted stock Number of Grant-Date Outstanding at beginning of year 429,399 $ 13.25 Granted 448,267 $ 15.78 Granted in lieu of cash 34,154 $ 9.18 Vested (161,263 ) $ 11.12 Forfeited (24,861 ) $ 14.80 Outstanding at September 30, 2020 725,696 $ 15.04 The aggregate fair value of the service vesting-based awards granted during the three September 30, 2020 2019 nine September 30, 2020 2019 three September 30, 2020 2019 nine September 30, 2020 2019 On March 25, 2020, 2019 September 25, 2020 December 31, 2019. We recognized stock compensation expense of $754,000 and $303,000 related to service vesting-based awards for the three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020, Performance-based restricted stock On March 25, 2020, 2020 December 31, 2020. The following is a summary of performance-based restricted stock activity for the nine September 30, 2020, September 30, 2020: Nine Month Period Ended September 30, 2020 Performance-based restricted stock Number of Grant-Date Outstanding at beginning of year — $ — Expected to vest 82,805 $ 9.18 Vested — $ — Forfeited — $ — Outstanding at September 30, 2020 82,805 $ 9.18 We recognized stock compensation expense of $191,000 and $569,000 related to performance-based restricted stock awards for the three nine September 30, 2020, September 30, 2020, Market-based restricted stock On February 25, 2019, April 1, 2019 January 1, 2019 December 31, 2020 20 2 0% December 31, 2020. On March 25, 2020, January 1, 2020 December 31, 2021 20 0% 2 December 31, 2021. We recognized stock compensation expense of $600,000 and $461,000 related to market-based restricted stock awards for the three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020, Total Stock Compensation Expense We recorded total stock compensation expense for the three nine September 30, 2020 2019, Three Month Period Ended Nine Month Period Ended September 30, September 30, (In thousands) 2020 2019 2020 2019 Research and development costs $ 291 $ 165 $ 687 $ 400 Sales and marketing costs 256 182 581 507 General and administrative costs 868 429 2,144 1,145 Cost of product sales 145 53 406 127 Total $ 1,560 $ 829 $ 3,818 $ 2,179

Note 8 - Warrants

Note 8 - Warrants	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Warrants [Text Block]	8. Warrants In March 2014, March 2021. In May 2016, May 2021. On May 14, 2020, Taurus4757 Additionally, during the three nine September 30, 2020, March 2021. The following table summarizes warrant activity for the nine September 30, 2020: Shares Wtd. Avg. Exercise Price Outstanding at December 31, 2019 3,959,005 $ 4.33 Exercised (3,879,905 ) 4.33 Outstanding at September 30, 2020 79,100 $ 4.75

Note 9 - Income Taxes

Note 9 - Income Taxes	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Income Tax Disclosure [Text Block]	9. Income Taxes The Company accounts for income taxes under ASC Topic 740 We have recorded a full valuation allowance against our deferred tax assets. If we have multiple quarters of positive net income, we will assess our valuation allowance. Based on all available evidence, we determined that we have not September 30, 2020. may On March 27, 2020, no 2020 As of March 30, 2020, 50% 2021 50% 2022.

Note 10 - Net Income (Loss) Per

Note 10 - Net Income (Loss) Per Common Share	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	10. Net Income (Loss) per Common Share The Company considers its unexercised warrants and unvested restricted shares, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two two three September 30, 2020, 63,000 nine September 30, 2019, 146,000 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands, except per share and share data) Basic earnings (loss) per common share Numerator: Net income (loss) $ (1,133 ) $ 10,269 $ 4,795 $ (4,640 ) Amount attributable to unvested restricted shares — (207 ) (138 ) — Amount attributable to warrants outstanding — (1,682 ) (335 ) — Net income (loss) allocated to common shareholders (1,133 ) 8,380 4,322 (4,640 ) Denominator: Weighted-average common shares issued and outstanding 31,639,420 19,735,364 25,418,375 19,071,722 Basic earnings (loss) per common share (0.04 ) 0.42 0.17 (0.24 ) Diluted earnings (loss) per common share Numerator: Net income (loss) (1,133 ) 10,269 4,795 (4,640 ) Amount attributable to non-participating warrants — (279 ) (49 ) — Less: gain related to change in fair value of warrants — (1,128 ) (4,467 ) — Diluted net income (loss) allocated to common shareholders (1,133 ) 8,862 279 (4,640 ) Denominator: Weighted-average common shares issued and outstanding 31,639,420 19,735,364 25,418,375 19,071,722 Dilutive potential common shares: Stock options — 2,420,884 1,754,051 — Restricted stock awards — 140,501 285,975 — Warrants — 3,046,363 1,954,137 — Diluted weighted-average shares issued and outstanding 31,639,420 25,343,112 29,412,538 19,071,722 Diluted earnings (loss) per common share (0.04 ) 0.35 0.01 (0.24 )

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	11. Commitments & Contingencies Employment agreements We have employment agreements with our Chief Executive Officer, Chief Financial and Operating Officer, Chief Science Officer, Chief Quality Officer, Chief Marketing Officer, Vice President - Freezer Technologies, Vice President of Sales - Thaw Technologies, Vice President of Product Development - Thaw Technologies, and Vice President - Global Sales. None may Litigation From time to time, the Company is subject to various legal proceedings that arise in the ordinary course of business, none may not Indemnification As permitted under Delaware law and in accordance with the Company’s bylaws, the Company is required to indemnify its officers and directors for certain errors and occurrences while the officer or director is or was serving in such capacity. The Company is also party to indemnification agreements with its directors. The Company believes the fair value of the indemnification rights and agreements is minimal. Accordingly, the Company has not September 30, 2020.

Note 12 - Revenue

Note 12 - Revenue	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	12. Revenue We currently operate as one We generate revenue from the sale of bioproduction products, equipment devices, and related consumables used with these equipment devices to customers in the life science and biopharmaceutical industries. Under ASC 606, The Company also generates revenue from the leasing of our evo cold chain systems, which are typically cloud-connected shippers with enabling cold chain cloud applications, to customers pursuant to rental arrangements entered into with the customer. Revenue from the rental of cold chain systems is not 606 842, The following table represents revenues by product line: Three Month Period Ended Nine Month Period Ended September 30, September 30, (In thousands) 2020 2019 2020 2019 Biopreservation media $ 7,414 $ 6,069 $ 22,753 $ 18,165 Automated thawing 277 324 1,047 699 evo shippers 494 211 1,372 211 Freezers and accessories 3,094 — 8,189 — Total $ 11,279 $ 6,604 $ 33,361 $ 19,075

Note 13 - Leases

Note 13 - Leases	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Lessee, Leases [Text Block]	13. Leases We lease approximately 32,106 square feet in our Bothell, Washington headquarters. The term of our lease continues until July 31, 2021 two five first August 1, 2021, second first September 30, 2020, August October We lease approximately 1,250 square feet in our Menlo Park, California location. The lease is on a month-to-month term. In accordance with the lease agreement, the monthly base rent is approximately $5,000 at September 30, 2020. We lease approximately 9,932 square feet in our Albuquerque, New Mexico location. The term of our lease continues until December 31, 2021 two three first December 1, 2021, second December 1, 2024. September 30, 2020, We lease approximately 106,998 square feet in our Detroit, Michigan location. The term of our lease continues until November 30, 2020 one sixty November 12, 2020. not 842, not 12 two not September 30, 2020, Operating leases recorded on our condensed consolidated balance sheet are primarily related to our Bothell, Washington headquarters space lease and our Albuquerque, New Mexico, SAVSU, space lease. We have not not not one Our financing lease is related to research equipment. We used a weighted average discount rate of 6.5%, our market collateralized borrowing rate, and 8.1%, the weighted average implied interest on our leases, to determine our operating and financing lease liabilities, respectively. The weighted average remaining term of our operating and financing leases are 1 year and 0.4 years, respectively. We initially recognized $1.3 million in operating lease right of use assets and initially recognized $1.8 million in operating lease liabilities. Through the SAVSU acquisition we acquired $233,000 in operating lease right of use assets and acquired $232,000 in operating lease liabilities. The operating lease costs recognized in the three September 30, 2020 not nine September 30, 2020 not three nine September 30, 2020 three nine September 30, 2019, Maturities of our operating lease liabilities as of September 30, 2020 (In thousands) Operating Leases Financing Leases 2020 220 4 2021 559 2 Total lease payments 779 6 Less: interest (24 ) (1 ) Total present value of lease liabilities $ 755 $ 5

Note 14 - Condensed Consolidate

Note 14 - Condensed Consolidated Balance Sheet Detail	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	14. Condensed Consolidated Balance Sheet Detail Property and Equipment (In thousands) September 30, 2020 December 31, 2019 Property and equipment Leasehold improvements $ 2,145 $ 2,112 Furniture and computer equipment 827 794 Manufacturing and other equipment 5,707 5,187 Subtotal 8,679 8,093 Less: Accumulated depreciation (3,379 ) (2,521 ) Net property and equipment $ 5,300 $ 5,572 Depreciation expense for property and equipment was $296,000 and $114,000 for the three September 30, 2020 2019, nine September 30, 2020 2019, Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following: (In thousands) September 30, 2020 December 31, 2019 Accrued expenses and other current liabilities $ 275 $ 302 Other payables 208 1,018 Accrued compensation 2,538 1,554 Deferred revenue 334 324 Other 9 171 Total accrued expenses and other current liabilities $ 3,364 $ 3,369

Note 15 - Employee Benefit Plan

Note 15 - Employee Benefit Plan	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Defined Contribution Plan [Text Block]	15. Employee Benefit Plan The Company sponsors a 401 may three September 30, 2020 2019, nine September 30, 2020 2019,

Note 16 - Subsequent Event

Note 16 - Subsequent Event	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	16. Subsequent Event SciSafe Acquisition On October 1, 2020, October 1, 2020. January 2021. may 2021, 2022, 2023 2024 We incurred $179,000 of related acquisition costs for the three September 30, 2020, October 1, 2020. Due to the limited time since the acquisition date and the effort required to assess the fair value of assets acquired and liabilities assumed, the initial accounting for the business combination is incomplete at the time of this filing. As a result, the Company is unable to provide the amounts recognized for the major classes of assets acquired and liabilities assumed, acquisition contingencies and goodwill. Also, the Company is unable to provide pro forma revenues and earnings of the combined entity. This information is expected to be included in the Company's Annual Report on Form 10 December 31, 2020.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The condensed consolidated financial statements included herein have been prepared by BioLife Solutions, Inc. in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10 10 X not 10 December 31, 2019. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Astero Bio Corporation (“Astero,” and the Astero product line, “ThawSTAR” acquired on April 1, 2019), August 8, 2019), November 12, 2019). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows. The results of operations for the interim periods presented are not Financial Statement Reclassification Certain classifications on the Condensed Consolidated Statements of Cash Flows related to non cash lease expense and accrued expenses and other current liabilities for the three nine September 30, 2019 no
Liquidity and Capital Resources, Policy [Policy Text Block]	Liquidity and Capital Resources On September 30, 2020 December 31, 2019, April 1, 2019 2019 second 2020. August 8, 2019, not November 12, 2019, not October 1, 2020, not On July 7, 2020, As of September 30, 2020, third October 1, 2020, Based on our current expectations with respect to our future revenue and expenses, we believe that our current level of cash and cash equivalents including proceeds from the public offering, will be sufficient to meet our liquidity needs for at least the foreseeable future. However, the Company may 19 may not
Risk and Uncertainties, Policy [Policy Text Block]	Risks and Uncertainties COVID- 19 On March 10, 2020, 2, 2019 19” 19 19, not three March 31, 2020, second June 30, 2020, third September 30, 2020, third September 30, 2020 second June 30, 2020. may The Company reviews capital and amortizing intangible assets (long-lived assets) for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount may not 19 June 30, 2020 19. As a result of the Company’s outlook for near term revenue from the ThawSTAR and freezer product lines, estimated undiscounted cash flow projections were developed to determine if any impairment of the related intangible assets was warranted. After conducting such review, the Company determined that there was no impairment of the remaining long-lived assets as of June 30, 2020. 19 The Company revised the revenue projections for the ThawSTAR and freezer product lines in the second June 30, 2020 third September 30, 2020 two not June 30, 2020, September 30, 2020 third September 30, 2020. The Company may 19 third Any disruption and volatility in the global capital markets as a result of the pandemic may 19 not The ultimate extent to which the COVID- 19 19 On March 27, 2020, may As of March 30, 2020, 50% 2021 50% 2022.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of credit risk and business risk In the three September 30, 2020, nine September 30, 2020, three September 30, 2019, three nine September 30, 2019, No 10% nine September 30, 2020 2019. three September 30, 2020 2019, 2019 2020, December 31, 2020. September 30, 2020, December 31, 2019, The following table represents the Company’s total revenue by geographic area (based on the location of the customer): Three Months Ended September 30, Nine Months Ended September 30, Revenue by customers’ geographic locations 2020 2019 2020 2019 United States 73 % 76 % 73 % 70 % Canada 11 % 12 % 13 % 17 % Europe, Middle East, Africa (EMEA) 13 % 11 % 12 % 11 % Other 3 % 1 % 2 % 2 % Total revenue 100 % 100 % 100 % 100 %
New Accounting Pronouncements, Policy [Policy Text Block]	Recent accounting pronouncements In June 2016, No. 2016 13, 326 2016 13 2016 13 December 15, 2022, In August 2018, 2018 13, 820 2018 13 8: December 31, 2020 January 1, 2020 no In August 2018, No. 2018 15, 350 40 2018 15 December 15, 2019, January 1, 2020 no In December 2019, 2019 12, 740 2019 12 740, not 2019 12 December 31, 2021, no 2019 12

Note 1 - Organization and Sig_2

Note 1 - Organization and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, Revenue by customers’ geographic locations 2020 2019 2020 2019 United States 73 % 76 % 73 % 70 % Canada 11 % 12 % 13 % 17 % Europe, Middle East, Africa (EMEA) 13 % 11 % 12 % 11 % Other 3 % 1 % 2 % 2 % Total revenue 100 % 100 % 100 % 100 %

Note 2 - Fair Value Measureme_2

Note 2 - Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	As of September 30, 2020 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 93,984 $ — $ — $ 93,984 Restricted cash held in escrow 15,000 — — 15,000 Convertible debt held at fair value — — 2,110 2,110 Total 108,984 — 2,110 111,094 Liabilities: Contingent consideration - business combinations — — 386 386 Warrant liability — — 1,914 1,914 Total $ — $ — $ 2,300 $ 2,300 As of December 31, 2019 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,448 $ — $ — $ 6,448 Convertible debt held at fair value — — 1,000 1,000 Total 6,448 — 1,000 7,448 Liabilities: Contingent consideration - business combinations — — 1,914 1,914 Warrant liability — — 39,602 39,602 Total $ — $ — $ 41,516 $ 41,516
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 1,000 $ — $ 1,000 $ — Purchases — 1,000 — 1,000 Change in fair value recognized in net income 1,110 — 1,110 — Balance, end of period $ 2,110 $ 1,000 $ 2,110 $ 1,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 388 $ 1,492 $ 1,914 $ — Additions — — — 1,492 Change in fair value recognized in net income (2 ) — (1,528 ) — Payments earned, reclassified to accrued liabilities — — — — Balance, end of period $ 386 $ 1,492 $ 386 $ 1,492
Warrant Liabilities [Member]
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands) Balance, beginning of period $ 963 $ 44,194 $ 39,602 $ 28,516 Exercised warrants (54 ) (1,295 ) (33,221 ) (1,694 ) Change in fair value recognized in net income 1,005 (1,128 ) (4,467 ) 14,949 Balance, end of period $ 1,914 $ 41,771 $ 1,914 $ 41,771

Note 3 - Acquisitions (Tables)

Note 3 - Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Cash consideration $ 12,521 Contingent consideration 1,491 Working capital adjustment (71 ) Total consideration transferred $ 13,941 Stock consideration for 55.6% equity interest purchased $ 19,932 Cash consideration $ 11,000 Stock consideration 4,000 Contingent consideration 856 Total consideration transferred $ 15,856
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Cash and cash equivalents $ 11 Accounts receivable, net 154 Inventory 456 Customer relationships 160 Tradenames 470 Developed technology 2,840 In-process research and development 650 Goodwill 9,515 Other assets 99 Accounts payable (250 ) Other liabilities (164 ) Fair value of net assets acquired $ 13,941 Cash and cash equivalents $ 1,251 Accounts receivable, net 753 Prepaid expenses and other current assets 19 Property, plant and equipment, net 546 Operating right-of-use asset 233 Assets held for rent, net 2,441 Customer relationships 80 Tradenames 1,320 Developed technology 10,750 Goodwill 21,037 Accounts payable and accrued expenses (807 ) Deferred tax liabilities (1,541 ) Other liabilities (232 ) Fair value of net assets acquired $ 35,850 Accounts receivable, net $ 1,044 Inventory 3,232 Prepaid expenses and other current assets 29 Property, plant and equipment, net 3,615 Customer relationships 560 Tradenames 800 Developed technology 5,430 Goodwill 2,954 Accounts payable (1,197 ) Other liabilities (611 ) Fair value of net assets acquired $ 15,856
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 160 4 Tradenames 470 9 Developed technology 2,840 5 – 9 In-process research and development 650 9 Total identifiable intangible assets $ 4,120 Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 80 6 Tradenames 1,320 9 Developed technology 10,750 7 – 8 Total identifiable intangible assets $ 12,150 Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 560 6 Tradenames 800 6 Developed technology 5,430 9 Total identifiable intangible assets $ 6,790

Note 4 - Inventory (Tables)

Note 4 - Inventory (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Inventory, Current [Table Text Block]	(In thousands) September 30, 2020 December 31, 2019 Raw materials $ 2,731 $ 2,979 Work in progress 2,252 1,896 Finished goods 6,054 6,097 Total $ 11,037 $ 10,972

Note 5 - Assets Held for Rent (

Note 5 - Assets Held for Rent (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Scheduleof Assets Held for Rent [Table Text Block]	(In thousands) September 30, 2020 December 31, 2019 Shippers placed in service $ 4,666 $ 3,073 Accumulated deprecation (755 ) (174 ) Net 3,911 2,899 Shippers and related components in production 1,220 1,023 Total $ 5,131 $ 3,922

Note 6 - Goodwill and Intangi_2

Note 6 - Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Goodwill [Table Text Block]	(In thousands) Balance as of December 31, 2019 $ 33,637 Correction of an error related to CBS goodwill (131 ) Balance as of September 30, 2020 $ 33,506
Schedule of Finite-Lived Intangible Assets [Table Text Block]	(In thousands, except weighted average useful life) September 30, 2020 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (161 ) $ 639 4.5 Tradenames 2,590 (372 ) 2,218 6.9 Technology – acquired (1) 19,670 (2,646 ) 17,024 7.3 Total intangible assets $ 23,060 $ (3,179 ) $ 19,881 7.2 (In thousands, except weighted average useful life) December 31, 2019 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (51 ) $ 749 5.6 Tradenames 2,590 (123 ) 2,467 8.1 Technology – acquired 19,020 (904 ) 18,116 8.4 In-process R&D (2) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,078 ) $ 21,982 8.3
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	(In thousands) For the Years Ended December 31, Estimated Amortization Expense 2020 (3 months remaining) $ 705 2021 2,825 2022 2,825 2023 2,795 2024 2,770 Thereafter 7,961 Total $ 19,881

Note 7 - Share-based Compensa_2

Note 7 - Share-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Nine Month Period Ended September 30, 2020 Wtd. Avg. Exercise Options Price Outstanding at beginning of year 1,570,455 $ 1.96 Granted — $ — Exercised (511,680 ) $ 1.95 Forfeited — $ — Expired — $ — Outstanding service vesting-based at September 30, 2020 1,058,775 $ 1.96 Service vesting-based options exercisable at September 30, 2020 1,039,399 $ 1.94 Nine Month Period Ended September 30, 2020 Wtd. Avg. Exercise Options Price Outstanding at beginning of year 737,497 $ 1.64 Granted — $ — Exercised (17,113 ) $ 1.64 Outstanding performance-based at September 30, 2020 720,384 $ 1.64 Performance-based options exercisable at September 30, 2020 720,384 $ 1.64
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Nine Month Period Ended September 30, 2020 Service vesting-based restricted stock Number of Grant-Date Outstanding at beginning of year 429,399 $ 13.25 Granted 448,267 $ 15.78 Granted in lieu of cash 34,154 $ 9.18 Vested (161,263 ) $ 11.12 Forfeited (24,861 ) $ 14.80 Outstanding at September 30, 2020 725,696 $ 15.04 Nine Month Period Ended September 30, 2020 Performance-based restricted stock Number of Grant-Date Outstanding at beginning of year — $ — Expected to vest 82,805 $ 9.18 Vested — $ — Forfeited — $ — Outstanding at September 30, 2020 82,805 $ 9.18
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Month Period Ended Nine Month Period Ended September 30, September 30, (In thousands) 2020 2019 2020 2019 Research and development costs $ 291 $ 165 $ 687 $ 400 Sales and marketing costs 256 182 581 507 General and administrative costs 868 429 2,144 1,145 Cost of product sales 145 53 406 127 Total $ 1,560 $ 829 $ 3,818 $ 2,179

Note 8 - Warrants (Tables)

Note 8 - Warrants (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Shares Wtd. Avg. Exercise Price Outstanding at December 31, 2019 3,959,005 $ 4.33 Exercised (3,879,905 ) 4.33 Outstanding at September 30, 2020 79,100 $ 4.75

Note 10 - Net Income (Loss) P_2

Note 10 - Net Income (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (In thousands, except per share and share data) Basic earnings (loss) per common share Numerator: Net income (loss) $ (1,133 ) $ 10,269 $ 4,795 $ (4,640 ) Amount attributable to unvested restricted shares — (207 ) (138 ) — Amount attributable to warrants outstanding — (1,682 ) (335 ) — Net income (loss) allocated to common shareholders (1,133 ) 8,380 4,322 (4,640 ) Denominator: Weighted-average common shares issued and outstanding 31,639,420 19,735,364 25,418,375 19,071,722 Basic earnings (loss) per common share (0.04 ) 0.42 0.17 (0.24 ) Diluted earnings (loss) per common share Numerator: Net income (loss) (1,133 ) 10,269 4,795 (4,640 ) Amount attributable to non-participating warrants — (279 ) (49 ) — Less: gain related to change in fair value of warrants — (1,128 ) (4,467 ) — Diluted net income (loss) allocated to common shareholders (1,133 ) 8,862 279 (4,640 ) Denominator: Weighted-average common shares issued and outstanding 31,639,420 19,735,364 25,418,375 19,071,722 Dilutive potential common shares: Stock options — 2,420,884 1,754,051 — Restricted stock awards — 140,501 285,975 — Warrants — 3,046,363 1,954,137 — Diluted weighted-average shares issued and outstanding 31,639,420 25,343,112 29,412,538 19,071,722 Diluted earnings (loss) per common share (0.04 ) 0.35 0.01 (0.24 )

Note 12 - Revenue (Tables)

Note 12 - Revenue (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Revenues By Product Line [Table Text Block]	Three Month Period Ended Nine Month Period Ended September 30, September 30, (In thousands) 2020 2019 2020 2019 Biopreservation media $ 7,414 $ 6,069 $ 22,753 $ 18,165 Automated thawing 277 324 1,047 699 evo shippers 494 211 1,372 211 Freezers and accessories 3,094 — 8,189 — Total $ 11,279 $ 6,604 $ 33,361 $ 19,075

Note 13 - Leases (Tables)

Note 13 - Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	(In thousands) Operating Leases Financing Leases 2020 220 4 2021 559 2 Total lease payments 779 6 Less: interest (24 ) (1 ) Total present value of lease liabilities $ 755 $ 5

Note 14 - Condensed Consolida_2

Note 14 - Condensed Consolidated Balance Sheet Detail (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Property, Plant and Equipment [Table Text Block]	(In thousands) September 30, 2020 December 31, 2019 Property and equipment Leasehold improvements $ 2,145 $ 2,112 Furniture and computer equipment 827 794 Manufacturing and other equipment 5,707 5,187 Subtotal 8,679 8,093 Less: Accumulated depreciation (3,379 ) (2,521 ) Net property and equipment $ 5,300 $ 5,572
Schedule of Accrued Liabilities [Table Text Block]	(In thousands) September 30, 2020 December 31, 2019 Accrued expenses and other current liabilities $ 275 $ 302 Other payables 208 1,018 Accrued compensation 2,538 1,554 Deferred revenue 334 324 Other 9 171 Total accrued expenses and other current liabilities $ 3,364 $ 3,369

Note 1 - Organization and Sig_3

Note 1 - Organization and Significant Accounting Policies (Details Textual)	Oct. 01, 2020USD ($)shares	Jul. 07, 2020USD ($)$ / sharesshares	Nov. 12, 2019USD ($)	Aug. 08, 2019shares	Apr. 01, 2019USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Sep. 30, 2019	Jun. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance						$ 109,000,000				$ 109,000,000		$ 6,400,000
Payment for Contingent Consideration Liability, Financing Activities										483,000	$ 0
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable										0	$ 19,932,000
Stock Issued During Period, Shares, New Issues (in shares) | shares		5,951,250
Shares Issued, Price Per Share (in dollars per share) | $ / shares		$ 14.50
Payments of Stock Issuance Costs		$ 6,100,000								6,200,000
Proceeds from Issuance of Common Stock, Net		$ 80,200,000
Impairment of Intangible Assets (Excluding Goodwill), Total									$ 0
Business Combination, Contingent Consideration, Liability, Total						$ 386,000	$ 388,000		$ 388,000	$ 386,000
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage						11.00%		33.00%		12.00%	17.00%
Number of Major Customers						1				1	1
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage										32.00%		25.00%
Number of Major Customers										2		2
Product Concentration Risk [Member] | Revenue Benchmark [Member] | CryoStor Products [Member]
Concentration Risk, Percentage						62.00%		81.00%
Over-Allotment Option [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares		776,250
Astero [Member]
Payments to Acquire Businesses, Gross					$ 12,521,000
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High					8,500,000
Payment for Contingent Consideration Liability, Financing Activities							$ 483,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares				1,100,000
Payments to Acquire Businesses, Initial Cash Payment					8,000,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High					8,500,000
Business Combination, Contingent Consideration, Liability, Total					$ 1,500,000	$ 80,000				$ 80,000		$ 1,100,000
CBS Acquisition [Member]
Payments to Acquire Businesses, Gross			$ 11,000,000
Payments to Acquire Businesses, Initial Cash Payment			11,000,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			4,000,000
Business Combination, Contingent Consideration, Liability, Total						$ 306,000				$ 306,000		$ 856,000
CBS Acquisition [Member] | Earning Payments Payable in Each Calendar Year 2020, 2021, 2022, 2023, and 2024 [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 15,000,000
SciSafe Holdings, Inc [Member] | Subsequent Event [Member]
Payments to Acquire Businesses, Gross	$ 15,000,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares	611,383
Business Combination Contingent Consideration Stock Issuable High Range	$ 626,000

Note 1 - Organization and Sig_4

Note 1 - Organization and Significant Accounting Policies - Concentrations Risk by Geographic Locations (Details) - Revenue Benchmark [Member] - Geographic Concentration Risk [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue by customers’ geographic locations, percentage	100.00%	100.00%	100.00%	100.00%
UNITED STATES
Revenue by customers’ geographic locations, percentage	73.00%	76.00%	73.00%	70.00%
CANADA
Revenue by customers’ geographic locations, percentage	11.00%	12.00%	13.00%	17.00%
EMEA [Member]
Revenue by customers’ geographic locations, percentage	13.00%	11.00%	12.00%	11.00%
Geographic, Other [Member]
Revenue by customers’ geographic locations, percentage	3.00%	1.00%	2.00%	2.00%

Note 2 - Fair Value Measureme_3

Note 2 - Fair Value Measurement (Details Textual)	9 Months Ended
	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	Nov. 10, 2019	Apr. 01, 2019USD ($)
Business Combination, Contingent Consideration, Liability, Total	$ 386,000	$ 388,000
Astero [Member]
Business Combination, Contingent Consideration, Liability, Total	80,000		$ 1,100,000		$ 1,500,000
CBS Acquisition [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 306,000		$ 856,000
Measurement Input, Risk Free Interest Rate [Member] | CBS Acquisition [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	0.25			1.74
Measurement Input, Discount Rate [Member] | Astero [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	12.5				17.5
Measurement Input, Discount Rate [Member] | CBS Acquisition [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	23			26
Measurement Input, Price Volatility [Member] | Astero [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	64				90
Measurement Input, Price Volatility [Member] | CBS Acquisition [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	63			70
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member] | Astero [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	0.08				2.30
Minimum [Member] | Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	0.640
Maximum [Member]
Warrants and Rights Outstanding, Term (Year)	1 year
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member] | Astero [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	0.12				2.43
Maximum [Member] | Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	0.846
Convertible Debt Securities [Member] | Measurement Input, Risk Free Interest Rate [Member]
Debt Securities, Trading, Measurement Input	0.080
Convertible Debt Securities [Member] | Minimum [Member]
Debt Securities, Term (Year)	1 year
Convertible Debt Securities [Member] | Minimum [Member] | Measurement Input, Prepayment Rate [Member]
Debt Securities, Trading, Measurement Input	5
Convertible Debt Securities [Member] | Maximum [Member]
Debt Securities, Term (Year)	2 years
Convertible Debt Securities [Member] | Maximum [Member] | Measurement Input, Prepayment Rate [Member]
Debt Securities, Trading, Measurement Input	50

Note 2 - Fair Value Measureme_4

Note 2 - Fair Value Measurement - Financial Assets and Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Assets	$ 111,094	$ 7,448
Liabilities	2,300	41,516
Contingent Consideration Liabilities [Member]
Liabilities	386
Warrant Liabilities [Member]
Liabilities	1,914	39,602
Money Market Funds [Member]
Assets	93,984	6,448
Restricted Cash Held in Escrow [Member]
Assets	15,000
Convertible Debt Securities [Member]
Assets	2,110	1,000
Contingent Consideration Liabilities [Member]
Liabilities		1,914
Fair Value, Inputs, Level 1 [Member]
Assets	108,984	6,448
Liabilities	0	0
Fair Value, Inputs, Level 1 [Member] | Contingent Consideration Liabilities [Member]
Liabilities	0
Fair Value, Inputs, Level 1 [Member] | Warrant Liabilities [Member]
Liabilities	0	0
Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]
Assets	93,984	6,448
Fair Value, Inputs, Level 1 [Member] | Restricted Cash Held in Escrow [Member]
Assets	15,000
Fair Value, Inputs, Level 1 [Member] | Convertible Debt Securities [Member]
Assets	0	0
Fair Value, Inputs, Level 1 [Member] | Contingent Consideration Liabilities [Member]
Liabilities		0
Fair Value, Inputs, Level 2 [Member]
Assets	0	0
Liabilities	0	0
Fair Value, Inputs, Level 2 [Member] | Contingent Consideration Liabilities [Member]
Liabilities	0
Fair Value, Inputs, Level 2 [Member] | Warrant Liabilities [Member]
Liabilities	0	0
Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]
Assets	0	0
Fair Value, Inputs, Level 2 [Member] | Restricted Cash Held in Escrow [Member]
Assets	0
Fair Value, Inputs, Level 2 [Member] | Convertible Debt Securities [Member]
Assets	0	0
Fair Value, Inputs, Level 2 [Member] | Contingent Consideration Liabilities [Member]
Liabilities		0
Fair Value, Inputs, Level 3 [Member]
Assets	2,110	1,000
Liabilities	2,300	41,516
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liabilities [Member]
Liabilities	386
Fair Value, Inputs, Level 3 [Member] | Warrant Liabilities [Member]
Liabilities	1,914	39,602
Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]
Assets	0	0
Fair Value, Inputs, Level 3 [Member] | Restricted Cash Held in Escrow [Member]
Assets	0
Fair Value, Inputs, Level 3 [Member] | Convertible Debt Securities [Member]
Assets	$ 2,110	1,000
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liabilities [Member]
Liabilities		$ 1,914

Note 2 - Fair Value Measureme_5

Note 2 - Fair Value Measurement - Fair Value of Assets Using Level 3 Input (Details) - Investments [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Balance, beginning of period	$ 1,000	$ 0	$ 1,000	$ 0
Purchases	0	1,000	0	1,000
Change in fair value recognized in net income	1,110	0	1,110	0
Balance, end of period	$ 2,110	$ 1,000	$ 2,110	$ 1,000

Note 2 - Fair Value Measureme_6

Note 2 - Fair Value Measurement - Fair Value of Liabilities Using Level 3 Input (Details) - Contingent Consideration Liabilities [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Balance, beginning of period	$ 388	$ 1,492	$ 1,914	$ 0
Additions	0	0	0	1,492
Change in fair value recognized in net income	(2)	0	(1,528)	0
Payments earned, reclassified to accrued liabilities	0	0	0	0
Balance, end of period	$ 386	$ 1,492	$ 386	$ 1,492

Note 2 - Fair Value Measureme_7

Note 2 - Fair Value Measurement - Fair Value of Warrant Liabilities Using Level 3 Inputs (Details) - Warrant Liabilities [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Balance, beginning of period	$ 963	$ 44,194	$ 39,602	$ 28,516
Exercised warrants	(54)	(1,295)	(33,221)	(1,694)
Change in fair value recognized in net income	1,005	(1,128)	(4,467)	14,949
Balance, end of period	$ 1,914	$ 41,771	$ 1,914	$ 41,771

Note 3 - Acquisitions (Details

Note 3 - Acquisitions (Details Textual) - USD ($)	Nov. 12, 2019	Aug. 08, 2019	Apr. 01, 2019	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Nov. 11, 2019	Aug. 07, 2019	Mar. 31, 2019
Payment for Contingent Consideration Liability, Financing Activities							$ 483,000	$ 0
Business Combination, Contingent Consideration, Liability, Total				$ 386,000	$ 388,000		386,000
Goodwill, Ending Balance				33,506,000			33,506,000		$ 33,637,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable							0	19,932,000
Equity Method Investments				54,000			54,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net, Total				0		$ 10,108,000	0	$ 10,108,000
SAVSU [Member]
Equity Method Investments		$ 5,800,000
Astero [Member]
Payments to Acquire Businesses, Gross			$ 12,521,000
Payments to Acquire Businesses, Initial Cash Payment			8,000,000
Payments to Acquire Businesses, Deferred Cash Payment			4,500,000
Business Combination, Consideration Transferred, Liabilities Incurred			1,491,000
Payment for Contingent Consideration Liability, Financing Activities					$ 483,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			8,500,000
Business Combination, Contingent Consideration, Liability, Total			1,500,000	80,000			80,000		1,100,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets			324,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets			4,100,000
Goodwill, Ending Balance			9,500,000									$ 9,515,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount			1,100,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		1,100,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total												$ 13,941,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			4,120,000
Astero [Member] | Earnout Payments Payable in Each Calendar Years of 2019, 2020 and 2021 [Member]
Business Combination, Consideration Transferred, Liabilities Incurred			3,500,000
Astero [Member] | Earnout Payment for Calendar Year 2021 [Member]
Business Combination, Consideration Transferred, Liabilities Incurred			$ 5,000,000
SAVSU [Member]
Goodwill, Ending Balance		$ 19,500,000									$ 21,037,000
Business Combinations, Number of Shares Acquired (in shares)		8,616
Business Acquisition, Percentage of Voting Interests Acquired		56.00%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		1,100,000
Share Price (in dollars per share)		$ 18.12
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 19,932,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total		35,800,000									$ 35,850,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		$ 15,900,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage		44.00%
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net, Total		$ 10,100,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets, Net		4,200,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		12,150,000
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Total		$ 35,800,000
CBS Acquisition [Member]
Payments to Acquire Businesses, Gross	$ 11,000,000
Payments to Acquire Businesses, Initial Cash Payment	11,000,000
Business Combination, Consideration Transferred, Liabilities Incurred	856,000
Business Combination, Contingent Consideration, Liability, Total				$ 306,000			$ 306,000		$ 856,000
Goodwill, Ending Balance	3,100,000									$ 2,954,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	4,000,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total										15,856,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets, Net	6,000,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	6,800,000									$ 6,790,000
Business Combination, Consideration Transferred, Excluding Contingent Consideration	15,000,000
Business Combination, Cash Holdback Escrow to Satisfy Indemnification Claims	550,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Escrow Holdback	3,000,000
CBS Acquisition [Member] | Earning Payments Payable in Each Calendar Year 2020, 2021, 2022, 2023, and 2024 [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 15,000,000

Note 3 - Acquisitions - Conside

Note 3 - Acquisitions - Consideration (Details) - USD ($) $ in Thousands	Nov. 12, 2019	Aug. 08, 2019	Apr. 01, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock consideration				$ 0	$ 19,932
Astero [Member]
Cash consideration			$ 12,521
Contingent consideration			1,491
Working capital adjustment			(71)
Total consideration transferred			$ 13,941
SAVSU [Member]
Stock consideration		$ 19,932
CBS Acquisition [Member]
Cash consideration	$ 11,000
Contingent consideration	856
Total consideration transferred	15,856
Stock consideration	$ 4,000

Note 3 - Acquisitions - Consi_2

Note 3 - Acquisitions - Consideration (Details) (Parentheticals)	Aug. 08, 2019
SAVSU [Member]
Percentage equity interest purchased	56.00%

Note 3 - Acquisitions - Fair Va

Note 3 - Acquisitions - Fair Value of Net Assets Acquired (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Nov. 12, 2019	Nov. 11, 2019	Aug. 08, 2019	Aug. 07, 2019	Apr. 01, 2019	Mar. 31, 2019
Goodwill	$ 33,506,000	$ 33,637,000
Astero [Member]
Cash and cash equivalents								$ 11,000
Accounts receivable, net								154,000
Inventory								456,000
Intangible assets							$ 4,120,000
Goodwill							9,500,000	9,515,000
Other assets								99,000
Accounts payable								(250,000)
Other liabilities								164,000
Fair value of net assets acquired								13,941,000
Other liabilities								(164,000)
Fair value of net assets acquired								13,941,000
Inventory								456,000
Astero [Member] | Customer Relationships [Member]
Intangible assets							160,000	160,000
Astero [Member] | Trade Names [Member]
Intangible assets							470,000	470,000
Astero [Member] | Developed Technology Rights [Member]
Intangible assets							2,840,000	2,840,000
Astero [Member] | In Process Research and Development [Member]
Intangible assets							$ 650,000	$ 650,000
SAVSU [Member]
Cash and cash equivalents						$ 1,251,000
Accounts receivable, net						753,000
Intangible assets					$ 12,150,000
Goodwill					19,500,000	21,037,000
Accounts payable						(807,000)
Other liabilities						232,000
Fair value of net assets acquired					35,800,000	35,850,000
Prepaid expenses and other current assets						19,000
Property, plant and equipment, net						546,000
Operating right-of-use asset					233,000	233,000
Assets held for rent, net						2,441,000
Deferred tax liabilities						(1,541,000)
Other liabilities						(232,000)
Fair value of net assets acquired					35,800,000	35,850,000
SAVSU [Member] | Customer Relationships [Member]
Intangible assets					80,000	80,000
SAVSU [Member] | Trade Names [Member]
Intangible assets					$ 1,320,000	1,320,000
SAVSU [Member] | Developed Technology Rights [Member]
Intangible assets						$ 10,750,000
CBS Acquisition [Member]
Accounts receivable, net				$ 1,044,000
Inventory				3,232,000
Intangible assets			$ 6,800,000	6,790,000
Goodwill			$ 3,100,000	2,954,000
Accounts payable				(1,197,000)
Other liabilities				611,000
Fair value of net assets acquired				15,856,000
Prepaid expenses and other current assets				29,000
Property, plant and equipment, net				3,615,000
Other liabilities				(611,000)
Fair value of net assets acquired				15,856,000
Inventory				3,232,000
CBS Acquisition [Member] | Customer Relationships [Member]
Intangible assets				560,000
CBS Acquisition [Member] | Trade Names [Member]
Intangible assets				800,000
CBS Acquisition [Member] | Developed Technology Rights [Member]
Intangible assets				$ 5,430,000

Note 3 - Acquisitions - Acquire

Note 3 - Acquisitions - Acquired Intangible Assets (Details) - USD ($) $ in Thousands	Nov. 11, 2019	Aug. 08, 2019	Apr. 01, 2019	Sep. 30, 2020	Nov. 12, 2019	Aug. 07, 2019	Mar. 31, 2019
Intangible assets, estimated useful life (Year)				9 years
Astero [Member]
Intangible assets			$ 4,120
Astero [Member] | Customer Relationships [Member]
Intangible assets			$ 160				$ 160
Intangible assets, estimated useful life (Year)			4 years
Astero [Member] | Trade Names [Member]
Intangible assets			$ 470				470
Intangible assets, estimated useful life (Year)			9 years
Astero [Member] | Developed Technology Rights [Member]
Intangible assets			$ 2,840				2,840
Astero [Member] | Developed Technology Rights [Member] | Minimum [Member]
Intangible assets, estimated useful life (Year)			5 years
Astero [Member] | Developed Technology Rights [Member] | Maximum [Member]
Intangible assets, estimated useful life (Year)			9 years
Astero [Member] | In Process Research and Development [Member]
Intangible assets			$ 650				$ 650
Intangible assets, estimated useful life (Year)			9 years
SAVSU [Member]
Intangible assets		$ 12,150
SAVSU [Member] | Customer Relationships [Member]
Intangible assets		$ 80				$ 80
Intangible assets, estimated useful life (Year)		6 years
SAVSU [Member] | Trade Names [Member]
Intangible assets		$ 1,320				1,320
Intangible assets, estimated useful life (Year)		9 years
SAVSU [Member] | Developed Technology Rights [Member]
Intangible assets						$ 10,750
SAVSU [Member] | Technology-Based Intangible Assets [Member]
Intangible assets		$ 10,750
SAVSU [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]
Intangible assets, estimated useful life (Year)		7 years
SAVSU [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]
Intangible assets, estimated useful life (Year)		8 years
CBS Acquisition [Member]
Intangible assets	$ 6,790				$ 6,800
CBS Acquisition [Member] | Customer Relationships [Member]
Intangible assets	$ 560
Intangible assets, estimated useful life (Year)	6 years
CBS Acquisition [Member] | Trade Names [Member]
Intangible assets	$ 800
Intangible assets, estimated useful life (Year)	6 years
CBS Acquisition [Member] | Developed Technology Rights [Member]
Intangible assets	$ 5,430
Intangible assets, estimated useful life (Year)	9 years

Note 4 - Inventory - Summary of

Note 4 - Inventory - Summary of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Raw materials	$ 2,731	$ 2,979
Work in progress	2,252	1,896
Finished goods	6,054	6,097
Total	$ 11,037	$ 10,972

Note 5 - Assets Held for Rent_2

Note 5 - Assets Held for Rent (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Assets Held for Rent, Depreciation	$ 186,000	$ 51,000	$ 581,000	$ 51,000

Note 5 - Assets Held for Rent -

Note 5 - Assets Held for Rent - Assets Held for Rent (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Shippers placed in service	$ 4,666	$ 3,073
Accumulated deprecation	(755)	(174)
Net	3,911	2,899
Shippers and related components in production	1,220	1,023
Total	$ 5,131	$ 3,922

Note 6 - Goodwill and Intangi_3

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($)	Apr. 01, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill, Purchase Accounting Adjustments				$ (131,000)
Increase (Decrease) in Accounts Payable, Total				(604,000)	$ 377,000
Amortization of Intangible Assets, Total		$ 706,000	$ 361,000	$ 2,100,000	$ 465,000
Finite-Lived Intangible Asset, Useful Life (Year)				9 years
In Process Research and Development [Member]
Finite-Lived Intangible Assets, Period Increase (Decrease), Total	$ (650,000)
CBS Acquisition [Member] | Immaterial Error [Member]
Goodwill, Purchase Accounting Adjustments				$ (131,000)
Increase (Decrease) in Accounts Payable, Total				$ (131,000)

Note 6 - Goodwill and Intangi_4

Note 6 - Goodwill and Intangible Assets - Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Balance	$ 33,637
Correction of an error related to CBS goodwill	(131)
Balance	$ 33,506

Note 6 - Goodwill and Intangi_5

Note 6 - Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
		Sep. 30, 2020		Dec. 31, 2019
Gross Carrying Value		$ 23,060		$ 23,060
Accumulated Amortization		(3,179)		(1,078)
Net Carrying Value		$ 19,881		$ 21,982
Weighted Average Useful Life (Year)		9 years
Weighted Average [Member]
Weighted Average Useful Life (Year)		7 years 2 months 12 days		8 years 3 months 18 days
Customer Relationships [Member]
Gross Carrying Value		$ 800		$ 800
Accumulated Amortization		(161)		(51)
Net Carrying Value		$ 639		$ 749
Customer Relationships [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		4 years 6 months		5 years 7 months 6 days
Trade Names [Member]
Gross Carrying Value		$ 2,590		$ 2,590
Accumulated Amortization		(372)		(123)
Net Carrying Value		$ 2,218		$ 2,467
Trade Names [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		6 years 10 months 24 days		8 years 1 month 6 days
Technology-Based Intangible Assets [Member]
Gross Carrying Value		$ 19,670	[1]	$ 19,020
Accumulated Amortization		(2,646)		(904)
Net Carrying Value		$ 17,024	[1]	$ 18,116
Technology-Based Intangible Assets [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		7 years 3 months 18 days		8 years 4 months 24 days
In Process Research and Development [Member]
Gross Carrying Value	[2]			$ 650
Accumulated Amortization	[2]			0
Net Carrying Value	[2]			$ 650
In Process Research and Development [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)	[2]			9 years
[1]	We transferred $650,000 out of “in-process R&D” into “Technology - acquired” on April 1, 2020, which was the date on which the product line became technologically feasible.
[2]	In-process R&D represents the fair value of incomplete research and development that has not yet reached technological feasibility. On April 1, 2020, we began amortizing the asset since it reached technological feasibility (see footnote 1 above).

Note 6 - Goodwill and Intangi_6

Note 6 - Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
2020 (3 months remaining)	$ 705
2021	2,825
2022	2,825
2023	2,795
2024	2,770
Thereafter	7,961
Total	$ 19,881	$ 21,982

Note 7 - Share-based Compensa_3

Note 7 - Share-based Compensation (Details Textual) - USD ($)	Mar. 25, 2020	Apr. 01, 2019	Feb. 25, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Expense				$ 1,560,000	$ 829,000	$ 3,818,000	$ 2,179,000
Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Expense				15,000	65,000	104,000	305,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value				28,600,000		28,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value				28,100,000		28,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value				2,200,000	1,700,000	$ 6,800,000	$ 5,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)						0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Year)						3 years 9 months 18 days
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				43,000		$ 43,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						1 year
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)						0
Performance Shares [Member] | Management Performance Bonus Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value				19,700,000		$ 19,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value				$ 0	$ 2,300,000	$ 239,000	$ 2,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)				0	0	0	0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						1 year 2 months 12 days
Restricted Stock [Member]
Share-based Payment Arrangement, Expense				$ 754,000	$ 303,000	$ 1,600,000	$ 826,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				10,000,000		$ 10,000,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						3 years 3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value				4,200,000	802,000,000,000	$ 7,400,000	4,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value				1,600,000	368,000	$ 2,900,000	1,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)						448,267
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)						$ 15.78
Restricted Stock [Member] | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	34,154					34,154
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18					$ 9.18
Performance-based Restricted Stock [Member]
Share-based Payment Arrangement, Expense				191,000		$ 569,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				191,000		$ 191,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	82,805					82,805
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18					$ 9.18
Performance-based Restricted Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	0.00%
Performance-based Restricted Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	125.00%
Market-based Restricted Stock [Member]
Share-based Payment Arrangement, Expense				600,000	$ 461,000	$ 1,500,000	$ 1,000,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 1,300,000		$ 1,300,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						10 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	109,140	29,604	94,247
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance	78.00%	69.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	0.30%	2.50%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	2 years	2 years
Market-based Restricted Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	0.00%	0.00%
Market-based Restricted Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	200.00%	200.00%

Note 7 - Share-based Compensa_4

Note 7 - Share-based Compensation - Stock Option Activity (Details)	9 Months Ended
	Sep. 30, 2020$ / sharesshares	Sep. 30, 2019shares
Share-based Payment Arrangement, Option [Member]
Outstanding (in shares) | shares	1,570,455
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 1.96
Granted (in shares) | shares	0	0
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 0
Exercised (in shares) | shares	(511,680)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 1.95
Forfeited (in shares) | shares	0
Forfeited, weighted average exercise price (in dollars per share) | $ / shares	$ 0
Expired (in shares) | shares	0
Expired, weighted average exercise price (in dollars per share) | $ / shares	$ 0
Outstanding (in shares) | shares	1,058,775
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 1.96
Options exercisable (in shares) | shares	1,039,399
Options exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 1.94
Performance Shares [Member]
Outstanding (in shares) | shares	737,497
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 1.64
Granted (in shares) | shares	0
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 0
Exercised (in shares) | shares	(17,113)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 1.64
Outstanding (in shares) | shares	720,384
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 1.64
Options exercisable (in shares) | shares	720,384
Options exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 1.64

Note 7 - Share-based Compensa_5

Note 7 - Share-based Compensation - Restricted Stock Activity (Details) - $ / shares	Mar. 25, 2020	Sep. 30, 2020
Restricted Stock [Member]
Outstanding (in shares)		429,399
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		448,267
Vested (in shares)		(161,263)
Forfeited (in shares)		(24,861)
Expected to vest (in shares)		448,267
Outstanding (in shares)		725,696
Outstanding (in dollars per share)		$ 13.25
Granted, grant date fair value (in dollars per share)		15.78
Vested, grant date fair value (in dollars per share)		11.12
Forfeited, grant date fair value (in dollars per share)		14.80
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		15.78
Outstanding (in dollars per share)		$ 15.04
Restricted Stock [Member] | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	34,154	34,154
Expected to vest (in shares)	34,154	34,154
Granted, grant date fair value (in dollars per share)	$ 9.18	$ 9.18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18	$ 9.18
Performance-based Restricted Stock [Member]
Outstanding (in shares)		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	82,805	82,805
Vested (in shares)		0
Forfeited (in shares)		0
Expected to vest (in shares)	82,805	82,805
Outstanding (in shares)		82,805
Outstanding (in dollars per share)		$ 0
Granted, grant date fair value (in dollars per share)	$ 9.18	9.18
Vested, grant date fair value (in dollars per share)		0
Forfeited, grant date fair value (in dollars per share)		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18	9.18
Outstanding (in dollars per share)		$ 9.18

Note 7 - Share-based Compensa_6

Note 7 - Share-based Compensation - Stock Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock compensation expense	$ 1,560	$ 829	$ 3,818	$ 2,179
Research and Development Expense [Member]
Stock compensation expense	291	165	687	400
Selling and Marketing Expense [Member]
Stock compensation expense	256	182	581	507
General and Administrative Expense [Member]
Stock compensation expense	868	429	2,144	1,145
Cost of Sales [Member]
Stock compensation expense	$ 145	$ 53	$ 406	$ 127

Note 8 - Warrants (Details Text

Note 8 - Warrants (Details Textual) - USD ($)	May 14, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	May 31, 2016	Mar. 31, 2014
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 4.75	$ 4.75		$ 4.33
Class of Warrant or Right, Exercised During Period (in shares)			3,879,905
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)			$ 4.33
Proceeds from Warrant Exercises			$ 40,000	$ 553,000
Warrants to Purchase Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)							6,910,283
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)							$ 4.75
Warrants in Connection with WAVI Credit Facility [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)						550,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)						$ 1.75
WAVI Holding AG and Taurus4757 GmbH Warrants [Member]
Stock Issued During Period, Shares, Cashless Warrant Exercises (in shares)	2,747,970
Class of Warrant or Right, Exercised During Period (in shares)	3,871,405		3,871,405
Warrants Expiring March 2021 [Member]
Class of Warrant or Right, Exercised During Period (in shares)		3,500	8,500
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)		$ 4.75	$ 4.75
Proceeds from Warrant Exercises		$ 17,000	$ 40,000

Note 8 - Warrants - Summary of

Note 8 - Warrants - Summary of Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Outstanding, number of shares (in shares) | shares	3,959,005
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 4.33
Exercised, number of shares (in shares) | shares	(3,879,905)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 4.33
Outstanding, number of shares (in shares) | shares	79,100
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 4.75

Note 10 - Net Income (Loss) P_3

Note 10 - Net Income (Loss) Per Common Share (Details Textual) - shares	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,900,000	2,500,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	63,000	3
Share-based Payment Arrangement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	286,000	146,000

Note 10 - Net Income (Loss) P_4

Note 10 - Net Income (Loss) Per Common Share - Calculation of Diluted Shares (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net income (loss)	$ (1,133)	$ 10,269	$ 4,795	$ (4,640)
Amount attributable to unvested restricted shares	0	(207)	(138)	0
Amount attributable to warrants outstanding	0	(1,682)	(335)	0
Net income (loss) allocated to common shareholders	$ (1,133)	$ 8,380	$ 4,322	$ (4,640)
Basic (in shares)	31,639,420	19,735,364	25,418,375	19,071,722
Basic earnings (loss) per common share (in dollars per share)	$ (0.04)	$ 0.42	$ 0.17	$ (0.24)
Amount attributable to non-participating warrants	$ 0	$ 279	$ 49	$ 0
Less: gain related to change in fair value of warrants	0	1,128	4,467	0
Diluted net income (loss) allocated to common shareholders	$ (1,133)	$ 8,862	$ 279	$ (4,640)
Warrants (in shares)	0	3,046,363	1,954,137	0
Diluted weighted-average shares issued and outstanding (in shares)	31,639,420	25,343,112	29,412,538	19,071,722
Diluted earnings (loss) per common share (in dollars per share)	$ (0.04)	$ 0.35	$ 0.01	$ (0.24)
Share-based Payment Arrangement, Option [Member]
Share-based payment arrangements (in shares)	0	2,420,884	1,754,051	0
Restricted Stock [Member]
Share-based payment arrangements (in shares)	0	140,501	285,975	0

Note 12 - Revenue - Revenues by

Note 12 - Revenue - Revenues by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Total revenue	$ 11,279	$ 6,604	$ 33,361	$ 19,075
Biopreservation Media [Member]
Total revenue	7,414	6,069	22,753	18,165
Automated Thawing Products [Member]
Total revenue	277	324	1,047	699
Evo Shippers [Member]
Total revenue	494	211	1,372	211
Freezers and Accessories [Member]
Total revenue	$ 3,094	$ 0	$ 8,189	$ 0

Note 13 - Leases (Details Textu

Note 13 - Leases (Details Textual)	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)ft²a	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)ft²a	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)	Aug. 08, 2019USD ($)	Aug. 07, 2019USD ($)	Jan. 01, 2019USD ($)
Operating Lease, Weighted Average Discount Rate, Percent	6.50%		6.50%
Finance Lease, Weighted Average Discount Rate, Percent	8.10%		8.10%
Operating Lease, Weighted Average Remaining Lease Term (Year)	1 year		1 year
Finance Lease, Weighted Average Remaining Lease Term (Year)	4 months 24 days		4 months 24 days
Operating Lease, Right-of-Use Asset	$ 585,000		$ 585,000		$ 1,040,000			$ 1,300,000
Operating Lease, Liability, Total	755,000		755,000					$ 1,800,000
Lease Cost, Operating Leases	229,000		685,000
Operating Lease, Cost	170,000		509,000
Short-term Lease, Cost	59,000		176,000
Variable Lease, Cost	0		0
Operating Lease, Payments	$ 219,000		$ 653,000
Operating Lease, Expense		$ 160,000		$ 444,000
SAVSU [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Asset						$ 233,000	$ 233,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability						$ 232,000
Bothell, Washington Headquarters [Member]
Area of Real Estate Property (Square Foot) | ft²	32,106		32,106
Lessee, Operating Lease, Renewal Term (Year)	5 years		5 years
Monthly Base Rent Expense			$ 63,000
Menlo Park, California Location [Member]
Area of Real Estate Property (Square Foot) | ft²	1,250		1,250
Monthly Base Rent Expense			$ 5,000
Albuquerque, New Mexico Location [Member]
Area of Real Estate Property (Square Foot) | ft²	9,932		9,932
Lessee, Operating Lease, Renewal Term (Year)	3 years		3 years
Monthly Base Rent Expense			$ 9,000
Detroit, Michigan Location [Member]
Area of Real Estate Property (Square Foot) | a	106,998		106,998
Lessee, Operating Lease, Renewal Term (Year)	60 months		60 months
Monthly Base Rent Expense			$ 15,000

Note 13 - Leases - Maturities o

Note 13 - Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jan. 01, 2019
2020, operating leases	$ 220
2020, finance leases	4
2021, operating leases	559
2021, finance leases	2
Total operating lease payments	779
Total financing lease payments	6
Less: operating lease interest	(24)
Less: financing lease interest	(1)
Total present value of operating lease liabilities	755	$ 1,800
Total present value of financing lease liabilities	$ 5

Note 14 - Condensed Consolida_3

Note 14 - Condensed Consolidated Balance Sheet Detail (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Depreciation, Total	$ 296,000	$ 114,000	$ 873,000	$ 322,000

Note 14 - Condensed Consolida_4

Note 14 - Condensed Consolidated Balance Sheet Detail - Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Property and equipment	$ 8,679	$ 8,093
Less: Accumulated depreciation	(3,379)	(2,521)
Net property and equipment	5,300	5,572
Leasehold Improvements [Member]
Property and equipment	2,145	2,112
Furniture and Computer Equipment [Member]
Property and equipment	827	794
Manufacturing Facility [Member]
Property and equipment	$ 5,707	$ 5,187

Note 14 - Condensed Consolida_5

Note 14 - Condensed Consolidated Balance Sheet Detail - Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accrued expenses and other current liabilities	$ 275	$ 302
Other payables	208	1,018
Accrued compensation	2,538	1,554
Deferred revenue	334	324
Other	9	171
Total accrued expenses and other current liabilities	$ 3,364	$ 3,369

Note 15 - Employee Benefit Pl_2

Note 15 - Employee Benefit Plan (Details Textual) - Defined Contribution Plan, 401 K [Member] - Pension Plan [Member] - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay			100.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 89,000	$ 33,000	$ 268,000	$ 113,000

Note 16 - Subsequent Event (Det

Note 16 - Subsequent Event (Details Textual) - USD ($)	Oct. 01, 2020	Jan. 31, 2021	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Business Combination, Acquisition Related Costs			$ 179,000	$ 291,000	$ 417,000	$ 538,000
SciSafe Holdings, Inc [Member]
Business Combination, Acquisition Related Costs			$ 179,000
SciSafe Holdings, Inc [Member] | Forecast [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		169,911
SciSafe Holdings, Inc [Member] | Subsequent Event [Member]
Payments to Acquire Businesses, Gross	$ 15,000,000
Stock Issued During Period, Shares, Acquisitions (in shares)	441,472
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	611,383
SciSafe Holdings, Inc [Member] | Subsequent Event [Member] | Maximum [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	626,000